Nuo Therapeutics, Inc. (AURX)
OTCMKTS
· Delayed Price · Currency is USD
1.144
-0.156 (-12.02%)
Apr 28, 2026, 4:00 PM EST
Nuo Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 0.55 | 0.28 | 0.93 | 2.05 | 1.41 | Upgrade
|
| Cash & Short-Term Investments | 0.55 | 0.28 | 0.93 | 2.05 | 1.41 | Upgrade
|
| Cash Growth | 93.49% | -69.45% | -54.73% | 45.01% | 776.26% | Upgrade
|
| Accounts Receivable | 0.56 | 0.25 | 0.25 | 0.09 | - | Upgrade
|
| Receivables | 0.56 | 0.25 | 0.25 | 0.09 | - | Upgrade
|
| Inventory | 0.21 | 0.15 | 0.21 | 0.24 | - | Upgrade
|
| Prepaid Expenses | 0.06 | 0.16 | 0.17 | 0.2 | 0.05 | Upgrade
|
| Restricted Cash | - | - | - | 0.06 | - | Upgrade
|
| Total Current Assets | 1.38 | 0.84 | 1.56 | 2.63 | 1.47 | Upgrade
|
| Property, Plant & Equipment | 0.47 | 0.35 | 0.31 | 0.41 | - | Upgrade
|
| Total Assets | 1.85 | 1.19 | 1.88 | 3.05 | 1.47 | Upgrade
|
| Accounts Payable | 0.44 | 0.22 | 0.39 | 0.4 | 0.53 | Upgrade
|
| Accrued Expenses | 0.49 | 0.29 | 0.19 | 0.12 | 0.15 | Upgrade
|
| Current Portion of Leases | 0.08 | 0.07 | 0.09 | 0.08 | - | Upgrade
|
| Current Unearned Revenue | 0.3 | - | - | - | - | Upgrade
|
| Total Current Liabilities | 1.31 | 0.58 | 0.67 | 0.6 | 0.67 | Upgrade
|
| Long-Term Leases | 0.02 | 0.1 | 0.16 | 0.26 | - | Upgrade
|
| Long-Term Unearned Revenue | 0.98 | - | - | - | - | Upgrade
|
| Other Long-Term Liabilities | 0.5 | - | - | -0 | - | Upgrade
|
| Total Liabilities | 2.8 | 0.68 | 0.84 | 0.86 | 0.67 | Upgrade
|
| Common Stock | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 33.81 | 32.77 | 30.97 | 28.95 | 24.38 | Upgrade
|
| Retained Earnings | -34.77 | -32.26 | -29.94 | -26.76 | -23.59 | Upgrade
|
| Total Common Equity | -0.96 | 0.51 | 1.04 | 2.19 | 0.79 | Upgrade
|
| Shareholders' Equity | -0.96 | 0.51 | 1.04 | 2.19 | 0.79 | Upgrade
|
| Total Liabilities & Equity | 1.85 | 1.19 | 1.88 | 3.05 | 1.47 | Upgrade
|
| Total Debt | 0.1 | 0.16 | 0.26 | 0.34 | - | Upgrade
|
| Net Cash (Debt) | 0.45 | 0.12 | 0.67 | 1.72 | 1.41 | Upgrade
|
| Net Cash Growth | 277.88% | -82.25% | -60.78% | 21.32% | 776.26% | Upgrade
|
| Net Cash Per Share | 0.01 | 0.00 | 0.02 | 0.04 | 0.05 | Upgrade
|
| Filing Date Shares Outstanding | 48.29 | 46.82 | 44.24 | 41.8 | 37.12 | Upgrade
|
| Total Common Shares Outstanding | 48.18 | 46.82 | 44.24 | 41.8 | 37.12 | Upgrade
|
| Working Capital | 0.07 | 0.26 | 0.89 | 2.03 | 0.79 | Upgrade
|
| Book Value Per Share | -0.02 | 0.01 | 0.02 | 0.05 | 0.02 | Upgrade
|
| Tangible Book Value | -0.96 | 0.51 | 1.04 | 2.19 | 0.79 | Upgrade
|
| Tangible Book Value Per Share | -0.02 | 0.01 | 0.02 | 0.05 | 0.02 | Upgrade
|
| Machinery | 0.88 | 0.61 | 0.45 | 0.45 | 0.39 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.